
In this study, we sought to determine the accuracy with which the International zzso of zzso 9th Edition, Clinical zzso zzso diagnosis code for zzso zzso of brain and spinal zzso in health insurance claims measures clinically evident central nervous system zzso zzso in patients with zzso cell lung cancer zzso For zzso consecutive patients with newly diagnosed zzso we compared zzso zzso zzso codes indicating tumor spread to the zzso from institutional billing records to zzso chart review to zzso zzso sensitivity, specificity and positive zzso value zzso of the zzso secondary zzso code and zzso the accuracy in time of its appearance within billing records compared with the gold standard date of zzso zzso The occurrence of at least one zzso code for brain zzso zzso 1) had a sensitivity of zzso zzso zzso zzso and zzso of zzso zzso zzso zzso By requiring zzso 2 codes zzso 2) or zzso 3 codes zzso 3) for the diagnosis of brain zzso in claims, specificity and zzso improved, while sensitivity did not drop zzso The zzso date of diagnosis was also accurate, with zzso of dates falling within 30 days of the gold zzso zzso codes in institutional billing claims reliably documented zzso zzso to the zzso These results suggest that Medicare claims data may be used to evaluate clinical and zzso issues related to brain zzso in elderly cancer zzso 

